Product Information
ZIOPTAN 0.0015% EYE DROP is a brand product labeled by Thea Pharma Inc., priced at $8.4909 per EA under NDC 82584060930. Its NADAC has been published 175 times since Apr 19, 2023.
FDA first approved this application on Feb 10, 2012. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Tafluprost market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.015 mg/mL
Manufacturer
Thea Pharma Inc.NDC
82584060930
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
TAFLUPROSTApproval Type
New Drug (NDA)
FDA Application
NDA202514FDA Approved
2/10/2012
TE Code
AT
On Market Since
10/28/2022
Pharmacological Classes
Price Statistics
The NADAC for ZIOPTAN 0.0015% EYE DROP has been published 175 times since Apr 19, 2023, and over the history we have for it it has risen 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4909 per EA |
|---|---|
| All-time high | $8.5184 (Dec 11, 2024) |
| All-time low | $7.3424 (Apr 19, 2023) |
| 52-week high | $8.4962 |
| 52-week low | $8.4857 |
| Median price | $8.4934 |
| Average price | $8.2962 |
| Largest weekly change | +8.0% (May 8, 2024) |
| Weeks tracked | 175 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIOPTAN 0.0015% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for ZIOPTAN 0.0015% EYE DROP, manufactured by Thea Pharma Inc., is $8.4909 per EA (NDC 82584060930), effective Aug 19, 2026.
How has the price of ZIOPTAN 0.0015% EYE DROP changed over time?
Over the history we have for it, the NADAC for ZIOPTAN 0.0015% EYE DROP has risen 15.6%. It has been tracked across 175 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for ZIOPTAN 0.0015% EYE DROP?
Since Apr 19, 2023, the NADAC for ZIOPTAN 0.0015% EYE DROP has ranged from a low of $7.3424 (Apr 19, 2023) to a high of $8.5184 (Dec 11, 2024), with a median of $8.4934 per EA.
Are there cheaper alternatives to ZIOPTAN 0.0015% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TAFLUPROST 0.0015% EYE DROP, is $2.4873 per EA — about 71% below ZIOPTAN 0.0015% EYE DROP.
Who manufactures ZIOPTAN 0.0015% EYE DROP?
ZIOPTAN 0.0015% EYE DROP (NDC 82584060930) is labeled by Thea Pharma Inc., and CMS classifies it as a brand product.